Dan YY - Search Results

1

Consensus cost-effectiveness model for treatment of chronic hepatitis B in Asia Pacific countries.

Dan YY, Wong JB, Hamid SS, Han KH, Jia JD, Liu CJ, Piratvisuth T, Lok AS, Lim SG. Dan YY, et al. Hepatol Int. 2014 Jul;8(3):382-94. doi: 10.1007/s12072-014-9549-1. Epub 2014 Jun 27. Hepatol Int. 2014. PMID: 26202640

2

Prophylactic strategies for hepatitis B patients undergoing liver transplant: a cost-effectiveness analysis.

Dan YY, Wai CT, Yeoh KG, Lim SG. Dan YY, et al. Liver Transpl. 2006 May;12(5):736-46. doi: 10.1002/lt.20685. Liver Transpl. 2006. PMID: 16628682 Free article.

3

A randomized, placebo-controlled trial of thymosin-alpha1 and lymphoblastoid interferon for HBeAg-positive chronic hepatitis B.

Lim SG, Wai CT, Lee YM, Dan YY, Sutedja DS, Wee A, Suresh S, Wu YJ, Machin D, Lim CC, Fock KM, Koay E, Bowden S, Locarnini S, Ishaque SM. Lim SG, et al. Among authors: dan yy. Antivir Ther. 2006;11(2):245-53. Antivir Ther. 2006. PMID: 16640105 Clinical Trial.

4

Non-invasive models for predicting histology in patients with chronic hepatitis B.

Wai CT, Cheng CL, Wee A, Dan YY, Chan E, Chua W, Mak B, Oo AM, Lim SG. Wai CT, et al. Among authors: dan yy. Liver Int. 2006 Aug;26(6):666-72. doi: 10.1111/j.1478-3231.2006.01287.x. Liver Int. 2006. PMID: 16842322

5

Applicability of cost-effectiveness analysis to management of chronic hepatitis B.

Dan YY, Lim SG. Dan YY, et al. J Gastroenterol Hepatol. 2007 Sep;22(9):1357-9. doi: 10.1111/j.1440-1746.2007.05098.x. J Gastroenterol Hepatol. 2007. PMID: 17716341 No abstract available.

6

The economics of treating chronic hepatitis B in Asia.

Dan YY, Aung MO, Lim SG. Dan YY, et al. Hepatol Int. 2008 Sep;2(3):284-95. doi: 10.1007/s12072-008-9049-2. Epub 2008 May 1. Hepatol Int. 2008. PMID: 19669256 Free PMC article.

7

Alanine aminotransferase is an inadequate surrogate marker for detecting lamivudine resistance.

Lim LG, Aung MO, Seet BL, Tan C, Dan YY, Lee YM, Sutedja DS, Fernandes M, Lee GH, Koay E, Lim SG. Lim LG, et al. Among authors: dan yy. World J Gastroenterol. 2010 Oct 7;16(37):4691-6. doi: 10.3748/wjg.v16.i37.4691. World J Gastroenterol. 2010. PMID: 20872970 Free PMC article.

8

Risk factors for mortality in cirrhotic patients with sepsis.

Lim LG, Tan XX, Woo SJ, Dan YY, Lee YM, Lai V, Lim SG. Lim LG, et al. Among authors: dan yy. Hepatol Int. 2011 Sep;5(3):800-7. doi: 10.1007/s12072-011-9258-y. Epub 2011 Feb 13. Hepatol Int. 2011. PMID: 21484126

9

Clinical outcomes of lamivudine-adefovir therapy in chronic hepatitis B cirrhosis.

Lim SG, Aung MO, Mak B, Sutedja D, Lee YM, Lee GH, Fernandes M, Low HC, Lai V, Dan YY. Lim SG, et al. Among authors: dan yy. J Clin Gastroenterol. 2011 Oct;45(9):818-23. doi: 10.1097/MCG.0b013e318214ab5d. J Clin Gastroenterol. 2011. PMID: 21921845 Clinical Trial.

10

Intragastric balloon significantly improves nonalcoholic fatty liver disease activity score in obese patients with nonalcoholic steatohepatitis: a pilot study.

Lee YM, Low HC, Lim LG, Dan YY, Aung MO, Cheng CL, Wee A, Lim SG, Ho KY. Lee YM, et al. Among authors: dan yy. Gastrointest Endosc. 2012 Oct;76(4):756-60. doi: 10.1016/j.gie.2012.05.023. Epub 2012 Jul 27. Gastrointest Endosc. 2012. PMID: 22840293 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

177 results

Search Page

Filters